Case Report: Morbihan disease treated with tofacitinib successfully
IntroductionTo date, there is no standard treatment for Morbihan disease. Several studies have reported that Morbihan disease responds well to systemic corticosteroids (prednisone and prednisolone), systemic antibiotics (tetracyclines), antihistamines (ketotifen) and surgical therapy (Lymphaticoveno...
Main Authors: | Zi-Yun Li, Chao-Cheng Chi, Sui-Qing Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1177316/full |
Similar Items
-
Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report
by: Kai-Jun Zhu, et al.
Published: (2021-06-01) -
Dramatic response of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome to tofacitinib monotherapy: a case report
by: Stéphanie Dierckx, et al.
Published: (2024-02-01) -
Tofacitinib
by: Nilgün Şentürk
Published: (2022-04-01) -
Successful treatment of nail lichen planus with tofacitinib: a case report and review of the literature
by: Jundong Huang, et al.
Published: (2023-11-01) -
Morbihan disease
by: Małgorzata Dominiak, et al.
Published: (2021-02-01)